Arthritis drugs could help prevent memory loss after surgery

November 1, 2010, University of California - San Francisco

Anti-inflammatory drugs currently used to treat diseases such as rheumatoid arthritis may also help prevent cognitive decline after surgery, according to a new study led by researchers at UCSF and colleagues at Imperial College, London.

The research explains for the first time why many patients experience or other forms of cognitive dysfunction after surgery or critical illness, a process the researchers traced to a specific inflammatory response in the brain.

The findings could lead directly to human clinical trials in as short as 12 months, the authors said. Their work appears in an upcoming issue of the and will be online at http://www.pnas.org/papbyrecent.shtml.

For years, anesthesiologists and neurologists have struggled to explain why some patients, especially the elderly, experience confusion, learning disorders and memory loss after surgery.

While typically short-term, this delirium occurs widely in intensive care units, affecting between 28 and 92 percent of hospitalized patients, depending on their age, health status and type of surgery, the authors said. It also has been linked to poorer surgical outcomes, as well as an increased risk of mortality, inability to cope and possible permanent dementia.

Until now, no one has clearly understood what caused the disorder or how to treat it, according to senior author Mervyn Maze, MB ChB, Professor and Chair of the UCSF Department of Anesthesiology and Perioperative Care. The new research not only linked that response to an immune protein called (TNF-α), a cytokine, but also identified a likely drug therapy to prevent it, he said.

"Antibody therapies already are widely used against cytokines to prevent or treat inflammation, so we know that these are effective in humans," said Maze, who began the research as a member of the Imperial College faculty before joining UCSF. "This study suggests that one day we also might be able to use these therapies as a single, pre-surgical dose to prevent cognitive decline in susceptible patients."

Previous studies have linked post-operative cognitive decline with the rise in blood levels of interleukin-1 beta (IL-1β), a molecule involved in inflammation. For this study, Maze and his colleagues studied a protein called tumor necrosis factor (TNF-α), which is known to regulate the immune system's before interleukin-1 is produced.

Working with Sir Marc Feldmann, MB, PhD, FRS – a pioneer in cytokine research in inflammatory disorders and professor at the Kennedy Institute of Rheumatology at Imperial College, London – the team gave a single dose of anti-TNF monoclonal antibody to mice using a model of orthopedic surgery. They found that it successfully acted as a prophylaxis against this disorder, decreasing blood levels of IL-1β, while limiting inflammation in the brain and eliminating behavioral indications of cognitive decline.

The research suggests that the TNF protein acts "upstream" of IL-1 and triggers a cascade of immune responses during surgery that provokes the production of IL-1 in the brain, Maze said. That in turn contributes to after surgery or critical illness.

"This is an important observation, as it demonstrates that cytokines are potential therapeutic targets in a wider range of diseases, not just autoimmune disease and cancer for which they are known targets," Feldmann said. "Moreover, effective therapeutics already are available, with a known safety profile and modest cost if used short term."

More information: N Terrando et al. Tumor necrosis factor-α triggers a cytokine cascade yielding postoperative cognitive decline. Proceedings of the National Academy of Sciences, 1 November 2010.

Related Stories

Recommended for you

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

judloved
not rated yet Nov 03, 2010
Arthritis pain causes a great place that is affected which can be alleviated by vicodin, as indicated Findrxonline.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.